ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Mood Disorder Treatment Market Research Report 2025
Published Date: June 2025
|
Report Code: QYRE-Auto-39S9203
Home | Market Reports | Health| Mental Health| Depression
Global Mood Disorder Treatment Market Research Report 2022
BUY CHAPTERS

Global Mood Disorder Treatment Market Research Report 2025

Code: QYRE-Auto-39S9203
Report
June 2025
Pages:75
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Ectron
Alkermes plc
Eli Lilly and Company
Pfizer Inc
Mylan N.V.
Novartis
MECTA Corporation
Somatics, LLC.
Janssen Global Services, LLC (Johnson & Johnson)
Allergan (AbbVie Inc.)

Mood Disorder Treatment Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Mood Disorder Treatment Market

Mood Disorder Treatment Market

The global market for Mood Disorder Treatment was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Mood disorder treatment refers to the interventions and strategies used to manage and alleviate the symptoms of mood disorders, which are mental health conditions characterized by disturbances in mood, such as depression or bipolar disorder. The goal of treatment is to reduce symptoms, improve functioning, and enhance the overall quality of life for individuals affected by mood disorders.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Mood Disorder Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Mood Disorder Treatment.
The Mood Disorder Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Mood Disorder Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Mood Disorder Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Mood Disorder Treatment Market Report

Report Metric Details
Report Name Mood Disorder Treatment Market
CAGR 5%
Segment by Type
Segment by Application
  • Hospital
  • Specialty Clinic
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company MECTA Corporation, Ectron Limited, Somatics, LLC., Alkermes, Eli Lilly and Company, Janssen Global Services, LLC (Johnson & Johnson), Allergan (AbbVie Inc.), Pfizer Inc., Mylan N.V., Novartis AG
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Mood Disorder Treatment company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Mood Disorder Treatment Market report?

Ans: The main players in the Mood Disorder Treatment Market are MECTA Corporation, Ectron Limited, Somatics, LLC., Alkermes, Eli Lilly and Company, Janssen Global Services, LLC (Johnson & Johnson), Allergan (AbbVie Inc.), Pfizer Inc., Mylan N.V., Novartis AG

What are the Application segmentation covered in the Mood Disorder Treatment Market report?

Ans: The Applications covered in the Mood Disorder Treatment Market report are Hospital, Specialty Clinic, Others

What are the Type segmentation covered in the Mood Disorder Treatment Market report?

Ans: The Types covered in the Mood Disorder Treatment Market report are Medications, Psychotherapy, Brain Stimulation Therapies

Recommended Reports

Mental Health Disorders

Neurological Disorders

Pharmaceutical Treatments

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Mood Disorder Treatment Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Medications
1.2.3 Psychotherapy
1.2.4 Brain Stimulation Therapies
1.3 Market by Application
1.3.1 Global Mood Disorder Treatment Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Specialty Clinic
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Mood Disorder Treatment Market Perspective (2020-2031)
2.2 Global Mood Disorder Treatment Growth Trends by Region
2.2.1 Global Mood Disorder Treatment Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Mood Disorder Treatment Historic Market Size by Region (2020-2025)
2.2.3 Mood Disorder Treatment Forecasted Market Size by Region (2026-2031)
2.3 Mood Disorder Treatment Market Dynamics
2.3.1 Mood Disorder Treatment Industry Trends
2.3.2 Mood Disorder Treatment Market Drivers
2.3.3 Mood Disorder Treatment Market Challenges
2.3.4 Mood Disorder Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Mood Disorder Treatment Players by Revenue
3.1.1 Global Top Mood Disorder Treatment Players by Revenue (2020-2025)
3.1.2 Global Mood Disorder Treatment Revenue Market Share by Players (2020-2025)
3.2 Global Mood Disorder Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Mood Disorder Treatment Revenue
3.4 Global Mood Disorder Treatment Market Concentration Ratio
3.4.1 Global Mood Disorder Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Mood Disorder Treatment Revenue in 2024
3.5 Global Key Players of Mood Disorder Treatment Head office and Area Served
3.6 Global Key Players of Mood Disorder Treatment, Product and Application
3.7 Global Key Players of Mood Disorder Treatment, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Mood Disorder Treatment Breakdown Data by Type
4.1 Global Mood Disorder Treatment Historic Market Size by Type (2020-2025)
4.2 Global Mood Disorder Treatment Forecasted Market Size by Type (2026-2031)
5 Mood Disorder Treatment Breakdown Data by Application
5.1 Global Mood Disorder Treatment Historic Market Size by Application (2020-2025)
5.2 Global Mood Disorder Treatment Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Mood Disorder Treatment Market Size (2020-2031)
6.2 North America Mood Disorder Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Mood Disorder Treatment Market Size by Country (2020-2025)
6.4 North America Mood Disorder Treatment Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Mood Disorder Treatment Market Size (2020-2031)
7.2 Europe Mood Disorder Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Mood Disorder Treatment Market Size by Country (2020-2025)
7.4 Europe Mood Disorder Treatment Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Mood Disorder Treatment Market Size (2020-2031)
8.2 Asia-Pacific Mood Disorder Treatment Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Mood Disorder Treatment Market Size by Region (2020-2025)
8.4 Asia-Pacific Mood Disorder Treatment Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Mood Disorder Treatment Market Size (2020-2031)
9.2 Latin America Mood Disorder Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Mood Disorder Treatment Market Size by Country (2020-2025)
9.4 Latin America Mood Disorder Treatment Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Mood Disorder Treatment Market Size (2020-2031)
10.2 Middle East & Africa Mood Disorder Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Mood Disorder Treatment Market Size by Country (2020-2025)
10.4 Middle East & Africa Mood Disorder Treatment Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 MECTA Corporation
11.1.1 MECTA Corporation Company Details
11.1.2 MECTA Corporation Business Overview
11.1.3 MECTA Corporation Mood Disorder Treatment Introduction
11.1.4 MECTA Corporation Revenue in Mood Disorder Treatment Business (2020-2025)
11.1.5 MECTA Corporation Recent Development
11.2 Ectron Limited
11.2.1 Ectron Limited Company Details
11.2.2 Ectron Limited Business Overview
11.2.3 Ectron Limited Mood Disorder Treatment Introduction
11.2.4 Ectron Limited Revenue in Mood Disorder Treatment Business (2020-2025)
11.2.5 Ectron Limited Recent Development
11.3 Somatics, LLC.
11.3.1 Somatics, LLC. Company Details
11.3.2 Somatics, LLC. Business Overview
11.3.3 Somatics, LLC. Mood Disorder Treatment Introduction
11.3.4 Somatics, LLC. Revenue in Mood Disorder Treatment Business (2020-2025)
11.3.5 Somatics, LLC. Recent Development
11.4 Alkermes
11.4.1 Alkermes Company Details
11.4.2 Alkermes Business Overview
11.4.3 Alkermes Mood Disorder Treatment Introduction
11.4.4 Alkermes Revenue in Mood Disorder Treatment Business (2020-2025)
11.4.5 Alkermes Recent Development
11.5 Eli Lilly and Company
11.5.1 Eli Lilly and Company Company Details
11.5.2 Eli Lilly and Company Business Overview
11.5.3 Eli Lilly and Company Mood Disorder Treatment Introduction
11.5.4 Eli Lilly and Company Revenue in Mood Disorder Treatment Business (2020-2025)
11.5.5 Eli Lilly and Company Recent Development
11.6 Janssen Global Services, LLC (Johnson & Johnson)
11.6.1 Janssen Global Services, LLC (Johnson & Johnson) Company Details
11.6.2 Janssen Global Services, LLC (Johnson & Johnson) Business Overview
11.6.3 Janssen Global Services, LLC (Johnson & Johnson) Mood Disorder Treatment Introduction
11.6.4 Janssen Global Services, LLC (Johnson & Johnson) Revenue in Mood Disorder Treatment Business (2020-2025)
11.6.5 Janssen Global Services, LLC (Johnson & Johnson) Recent Development
11.7 Allergan (AbbVie Inc.)
11.7.1 Allergan (AbbVie Inc.) Company Details
11.7.2 Allergan (AbbVie Inc.) Business Overview
11.7.3 Allergan (AbbVie Inc.) Mood Disorder Treatment Introduction
11.7.4 Allergan (AbbVie Inc.) Revenue in Mood Disorder Treatment Business (2020-2025)
11.7.5 Allergan (AbbVie Inc.) Recent Development
11.8 Pfizer Inc.
11.8.1 Pfizer Inc. Company Details
11.8.2 Pfizer Inc. Business Overview
11.8.3 Pfizer Inc. Mood Disorder Treatment Introduction
11.8.4 Pfizer Inc. Revenue in Mood Disorder Treatment Business (2020-2025)
11.8.5 Pfizer Inc. Recent Development
11.9 Mylan N.V.
11.9.1 Mylan N.V. Company Details
11.9.2 Mylan N.V. Business Overview
11.9.3 Mylan N.V. Mood Disorder Treatment Introduction
11.9.4 Mylan N.V. Revenue in Mood Disorder Treatment Business (2020-2025)
11.9.5 Mylan N.V. Recent Development
11.10 Novartis AG
11.10.1 Novartis AG Company Details
11.10.2 Novartis AG Business Overview
11.10.3 Novartis AG Mood Disorder Treatment Introduction
11.10.4 Novartis AG Revenue in Mood Disorder Treatment Business (2020-2025)
11.10.5 Novartis AG Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Ectron
Alkermes plc
Eli Lilly and Company
Pfizer Inc
Mylan N.V.
Novartis
MECTA Corporation
Somatics, LLC.
Janssen Global Services, LLC (Johnson & Johnson)
Allergan (AbbVie Inc.)
List of Tables
 Table 1. Global Mood Disorder Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Medications
 Table 3. Key Players of Psychotherapy
 Table 4. Key Players of Brain Stimulation Therapies
 Table 5. Global Mood Disorder Treatment Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Mood Disorder Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 7. Global Mood Disorder Treatment Market Size by Region (2020-2025) & (US$ Million)
 Table 8. Global Mood Disorder Treatment Market Share by Region (2020-2025)
 Table 9. Global Mood Disorder Treatment Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 10. Global Mood Disorder Treatment Market Share by Region (2026-2031)
 Table 11. Mood Disorder Treatment Market Trends
 Table 12. Mood Disorder Treatment Market Drivers
 Table 13. Mood Disorder Treatment Market Challenges
 Table 14. Mood Disorder Treatment Market Restraints
 Table 15. Global Mood Disorder Treatment Revenue by Players (2020-2025) & (US$ Million)
 Table 16. Global Mood Disorder Treatment Market Share by Players (2020-2025)
 Table 17. Global Top Mood Disorder Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mood Disorder Treatment as of 2024)
 Table 18. Ranking of Global Top Mood Disorder Treatment Companies by Revenue (US$ Million) in 2024
 Table 19. Global 5 Largest Players Market Share by Mood Disorder Treatment Revenue (CR5 and HHI) & (2020-2025)
 Table 20. Global Key Players of Mood Disorder Treatment, Headquarters and Area Served
 Table 21. Global Key Players of Mood Disorder Treatment, Product and Application
 Table 22. Global Key Players of Mood Disorder Treatment, Date of Enter into This Industry
 Table 23. Mergers & Acquisitions, Expansion Plans
 Table 24. Global Mood Disorder Treatment Market Size by Type (2020-2025) & (US$ Million)
 Table 25. Global Mood Disorder Treatment Revenue Market Share by Type (2020-2025)
 Table 26. Global Mood Disorder Treatment Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 27. Global Mood Disorder Treatment Revenue Market Share by Type (2026-2031)
 Table 28. Global Mood Disorder Treatment Market Size by Application (2020-2025) & (US$ Million)
 Table 29. Global Mood Disorder Treatment Revenue Market Share by Application (2020-2025)
 Table 30. Global Mood Disorder Treatment Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 31. Global Mood Disorder Treatment Revenue Market Share by Application (2026-2031)
 Table 32. North America Mood Disorder Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 33. North America Mood Disorder Treatment Market Size by Country (2020-2025) & (US$ Million)
 Table 34. North America Mood Disorder Treatment Market Size by Country (2026-2031) & (US$ Million)
 Table 35. Europe Mood Disorder Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 36. Europe Mood Disorder Treatment Market Size by Country (2020-2025) & (US$ Million)
 Table 37. Europe Mood Disorder Treatment Market Size by Country (2026-2031) & (US$ Million)
 Table 38. Asia-Pacific Mood Disorder Treatment Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 39. Asia-Pacific Mood Disorder Treatment Market Size by Region (2020-2025) & (US$ Million)
 Table 40. Asia-Pacific Mood Disorder Treatment Market Size by Region (2026-2031) & (US$ Million)
 Table 41. Latin America Mood Disorder Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 42. Latin America Mood Disorder Treatment Market Size by Country (2020-2025) & (US$ Million)
 Table 43. Latin America Mood Disorder Treatment Market Size by Country (2026-2031) & (US$ Million)
 Table 44. Middle East & Africa Mood Disorder Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 45. Middle East & Africa Mood Disorder Treatment Market Size by Country (2020-2025) & (US$ Million)
 Table 46. Middle East & Africa Mood Disorder Treatment Market Size by Country (2026-2031) & (US$ Million)
 Table 47. MECTA Corporation Company Details
 Table 48. MECTA Corporation Business Overview
 Table 49. MECTA Corporation Mood Disorder Treatment Product
 Table 50. MECTA Corporation Revenue in Mood Disorder Treatment Business (2020-2025) & (US$ Million)
 Table 51. MECTA Corporation Recent Development
 Table 52. Ectron Limited Company Details
 Table 53. Ectron Limited Business Overview
 Table 54. Ectron Limited Mood Disorder Treatment Product
 Table 55. Ectron Limited Revenue in Mood Disorder Treatment Business (2020-2025) & (US$ Million)
 Table 56. Ectron Limited Recent Development
 Table 57. Somatics, LLC. Company Details
 Table 58. Somatics, LLC. Business Overview
 Table 59. Somatics, LLC. Mood Disorder Treatment Product
 Table 60. Somatics, LLC. Revenue in Mood Disorder Treatment Business (2020-2025) & (US$ Million)
 Table 61. Somatics, LLC. Recent Development
 Table 62. Alkermes Company Details
 Table 63. Alkermes Business Overview
 Table 64. Alkermes Mood Disorder Treatment Product
 Table 65. Alkermes Revenue in Mood Disorder Treatment Business (2020-2025) & (US$ Million)
 Table 66. Alkermes Recent Development
 Table 67. Eli Lilly and Company Company Details
 Table 68. Eli Lilly and Company Business Overview
 Table 69. Eli Lilly and Company Mood Disorder Treatment Product
 Table 70. Eli Lilly and Company Revenue in Mood Disorder Treatment Business (2020-2025) & (US$ Million)
 Table 71. Eli Lilly and Company Recent Development
 Table 72. Janssen Global Services, LLC (Johnson & Johnson) Company Details
 Table 73. Janssen Global Services, LLC (Johnson & Johnson) Business Overview
 Table 74. Janssen Global Services, LLC (Johnson & Johnson) Mood Disorder Treatment Product
 Table 75. Janssen Global Services, LLC (Johnson & Johnson) Revenue in Mood Disorder Treatment Business (2020-2025) & (US$ Million)
 Table 76. Janssen Global Services, LLC (Johnson & Johnson) Recent Development
 Table 77. Allergan (AbbVie Inc.) Company Details
 Table 78. Allergan (AbbVie Inc.) Business Overview
 Table 79. Allergan (AbbVie Inc.) Mood Disorder Treatment Product
 Table 80. Allergan (AbbVie Inc.) Revenue in Mood Disorder Treatment Business (2020-2025) & (US$ Million)
 Table 81. Allergan (AbbVie Inc.) Recent Development
 Table 82. Pfizer Inc. Company Details
 Table 83. Pfizer Inc. Business Overview
 Table 84. Pfizer Inc. Mood Disorder Treatment Product
 Table 85. Pfizer Inc. Revenue in Mood Disorder Treatment Business (2020-2025) & (US$ Million)
 Table 86. Pfizer Inc. Recent Development
 Table 87. Mylan N.V. Company Details
 Table 88. Mylan N.V. Business Overview
 Table 89. Mylan N.V. Mood Disorder Treatment Product
 Table 90. Mylan N.V. Revenue in Mood Disorder Treatment Business (2020-2025) & (US$ Million)
 Table 91. Mylan N.V. Recent Development
 Table 92. Novartis AG Company Details
 Table 93. Novartis AG Business Overview
 Table 94. Novartis AG Mood Disorder Treatment Product
 Table 95. Novartis AG Revenue in Mood Disorder Treatment Business (2020-2025) & (US$ Million)
 Table 96. Novartis AG Recent Development
 Table 97. Research Programs/Design for This Report
 Table 98. Key Data Information from Secondary Sources
 Table 99. Key Data Information from Primary Sources
 Table 100. Authors List of This Report


List of Figures
 Figure 1. Mood Disorder Treatment Picture
 Figure 2. Global Mood Disorder Treatment Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Mood Disorder Treatment Market Share by Type: 2024 VS 2031
 Figure 4. Medications Features
 Figure 5. Psychotherapy Features
 Figure 6. Brain Stimulation Therapies Features
 Figure 7. Global Mood Disorder Treatment Market Size by Application (2020-2031) & (US$ Million)
 Figure 8. Global Mood Disorder Treatment Market Share by Application: 2024 VS 2031
 Figure 9. Hospital Case Studies
 Figure 10. Specialty Clinic Case Studies
 Figure 11. Others Case Studies
 Figure 12. Mood Disorder Treatment Report Years Considered
 Figure 13. Global Mood Disorder Treatment Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 14. Global Mood Disorder Treatment Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global Mood Disorder Treatment Market Share by Region: 2024 VS 2031
 Figure 16. Global Mood Disorder Treatment Market Share by Players in 2024
 Figure 17. Global Top Mood Disorder Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mood Disorder Treatment as of 2024)
 Figure 18. The Top 10 and 5 Players Market Share by Mood Disorder Treatment Revenue in 2024
 Figure 19. North America Mood Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 20. North America Mood Disorder Treatment Market Share by Country (2020-2031)
 Figure 21. United States Mood Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Canada Mood Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Europe Mood Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Europe Mood Disorder Treatment Market Share by Country (2020-2031)
 Figure 25. Germany Mood Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. France Mood Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. U.K. Mood Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Italy Mood Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Russia Mood Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Nordic Countries Mood Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Asia-Pacific Mood Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Asia-Pacific Mood Disorder Treatment Market Share by Region (2020-2031)
 Figure 33. China Mood Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Japan Mood Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. South Korea Mood Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Southeast Asia Mood Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. India Mood Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Australia Mood Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Latin America Mood Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Latin America Mood Disorder Treatment Market Share by Country (2020-2031)
 Figure 41. Mexico Mood Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Brazil Mood Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Middle East & Africa Mood Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Middle East & Africa Mood Disorder Treatment Market Share by Country (2020-2031)
 Figure 45. Turkey Mood Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Saudi Arabia Mood Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. UAE Mood Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. MECTA Corporation Revenue Growth Rate in Mood Disorder Treatment Business (2020-2025)
 Figure 49. Ectron Limited Revenue Growth Rate in Mood Disorder Treatment Business (2020-2025)
 Figure 50. Somatics, LLC. Revenue Growth Rate in Mood Disorder Treatment Business (2020-2025)
 Figure 51. Alkermes Revenue Growth Rate in Mood Disorder Treatment Business (2020-2025)
 Figure 52. Eli Lilly and Company Revenue Growth Rate in Mood Disorder Treatment Business (2020-2025)
 Figure 53. Janssen Global Services, LLC (Johnson & Johnson) Revenue Growth Rate in Mood Disorder Treatment Business (2020-2025)
 Figure 54. Allergan (AbbVie Inc.) Revenue Growth Rate in Mood Disorder Treatment Business (2020-2025)
 Figure 55. Pfizer Inc. Revenue Growth Rate in Mood Disorder Treatment Business (2020-2025)
 Figure 56. Mylan N.V. Revenue Growth Rate in Mood Disorder Treatment Business (2020-2025)
 Figure 57. Novartis AG Revenue Growth Rate in Mood Disorder Treatment Business (2020-2025)
 Figure 58. Bottom-up and Top-down Approaches for This Report
 Figure 59. Data Triangulation
 Figure 60. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Leap India

SIMILAR REPORTS

Bipolar Disorders and Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Bipolar Disorder Medications Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Psychiatric Medications Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Lithium Medication Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Depression Treatment Device Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Treatment Resistant Depression Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Substance Use Disorder Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Mental Disorder App Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Psychiatric Medication Therapies Market Research Report 2024
Global Eye Disorders Treatments Market Research Report 2024
Music Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Sleep Disorder Therapies Market Research Report 2024
Autism Disorder and Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Treatment for Mental Health Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Tardive Dyskinesia Treatment Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Drugs for Treating Mental Disorders Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Bipolar Disorder Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Mood Stabilizers Market Research Report 2024
Global Bipolar Disorder Therapeutics Drugs Market Insights Forecast to 2030
Mental Disorders Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global Depressive Disorder Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-6Z6361
Mon Sep 08 00:00:00 UTC 2025

Add to Cart

Global Major Depressive Disorder (MDD) Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9N6266
Mon Sep 08 00:00:00 UTC 2025

Add to Cart

Global Major Depressive Disorder Therapeutic Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19F13948
Fri Sep 05 00:00:00 UTC 2025

Add to Cart

Global Major Depressive Disorder Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9J1966
Fri Sep 05 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions